Literature DB >> 22921303

Lycium barbarum polysaccharide stimulates proliferation of MCF-7 cells by the ERK pathway.

Lingling Shen1, Guang Du.   

Abstract

AIMS: The aim of this study was to investigate the anti-proliferative effect of Lycium barbarum polysaccharide (LBP) on MCF-7 cells. MAIN
METHODS: MCF-7 cells were treated with 0, 10, 30, 100, and 300 μg/ml LBP for 24 h. The cell cycle distribution was analyzed by flow cytometry. MEK inhibitor, U1206 also was added in MCF-7 cells to deal with LBP (300 μg/ml) for different times (0, 2, 4, 6, 8, 16, 24 h). Western blotting was used to indicate changes in the levels of ERK (extracellular signal-regulated protein kinase) and phosphorylation-ERK (p-ERK) to compare the relationship between ERK activity and LBP. The expressions of p53, p-p53 and p21 were observed by western blotting to analyze the relationship between p53 and ERK which was under the treatment of LBP. KEY
FINDINGS: The MCF-7 cell cycle was arrested in S phase with the treatment of LBP. The LBP can also activate ERK, which may be associated with p53 pathway. There was a dose-dependent increase in the relation between the degree of ERK activation and LBP. SIGNIFICANCE: LBP induces the anti-proliferation of MCF-7 cells by activating ERK.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22921303     DOI: 10.1016/j.lfs.2012.08.012

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Sulfated modification promotes the immunomodulatory bioactivities of Lyciumbarbarum polysaccharides in vitro.

Authors:  Junmin Wang; Beilei Ge; Chunyan Du; Jingli Xue; Yuwei Zhuang; Kun Xue
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 2.  An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides.

Authors:  Jiang Cheng; Zhi-Wei Zhou; Hui-Ping Sheng; Lan-Jie He; Xue-Wen Fan; Zhi-Xu He; Tao Sun; Xueji Zhang; Ruan Jin Zhao; Ling Gu; Chuanhai Cao; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-12-17       Impact factor: 4.162

3.  A novel anticancer property of Lycium barbarum polysaccharide in triggering ferroptosis of breast cancer cells.

Authors:  Xing DU; Jingjing Zhang; Ling Liu; Bo Xu; Hang Han; Wenjie Dai; Xiuying Pei; Xufeng Fu; Shaozhang Hou
Journal:  J Zhejiang Univ Sci B       Date:  2022-04-15       Impact factor: 3.066

Review 4.  Research Advances on Anti-Cancer Natural Products.

Authors:  Meng Guo; Jie Jin; Dong Zhao; Zheng Rong; Lu-Qi Cao; Ai-Hong Li; Xiao-Ying Sun; Li-Yi Jia; Yin-Di Wang; Ling Huang; Yi-Heng Li; Zhong-Jing He; Long Li; Rui-Kang Ma; Yi-Fan Lv; Ke-Ke Shao; Hui-Ling Cao
Journal:  Front Oncol       Date:  2022-05-06       Impact factor: 5.738

Review 5.  Extraction, Structural Characterization, and Biological Functions of Lycium Barbarum Polysaccharides: A Review.

Authors:  Xiaojing Tian; Tisong Liang; Yuanlin Liu; Gongtao Ding; Fumei Zhang; Zhongren Ma
Journal:  Biomolecules       Date:  2019-08-21

6.  A Systematic Review of Potential Therapeutic Use of Lycium Barbarum Polysaccharides in Disease.

Authors:  Sum Sum Kwok; Yashan Bu; Amy Cheuk-Yin Lo; Tommy Chung-Yan Chan; Kwok Fai So; Jimmy Shiu-Ming Lai; Kendrick Co Shih
Journal:  Biomed Res Int       Date:  2019-02-12       Impact factor: 3.411

7.  Lycium barbarum polysaccharide prevents focal cerebral ischemic injury by inhibiting neuronal apoptosis in mice.

Authors:  Tengfei Wang; Yuxiang Li; Yongsheng Wang; Ru Zhou; Lin Ma; Yinju Hao; Shaoju Jin; Juan Du; Chengjun Zhao; Tao Sun; Jianqiang Yu
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

8.  Simple nanoliposomes encapsulating Lycium barbarum polysaccharides as adjuvants improve humoral and cellular immunity in mice.

Authors:  Ruonan Bo; Yaqin Sun; Shuzhen Zhou; Ning Ou; Pengfei Gu; Zhenguang Liu; Yuanliang Hu; Jiaguo Liu; Deyun Wang
Journal:  Int J Nanomedicine       Date:  2017-08-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.